Biotechs cautious about cultivating new product pipelines: patent reforms, wavering VC activity rein in Big Pharma buyouts.(FINANCE): An article from: San Diego Business Journal

This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on August 2, 2010. The length of the article is 1028 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Biotechs cautious about cultivating new product pipelines: patent reforms, wavering VC activity rein in Big Pharma buyouts.(FINANCE)
Author: Mark Larson
Publication:San Diego Business Journal (Magazine/Journal)
Date: August 2, 2010
Publisher: CBJ, L.P.
Volume: 31 Issue: 31 Page: 19(2)

Distributed by Gale, a part of Cengage Learning